These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 12197546)

  • 1. The Rx-to-OTC switch of Claritin, Allegra, and Zyrtec: an unprecedented FDA response to petitioners and the protection of public health.
    Spencer HM
    Am Univ Law Rev; 2002 Jun; 51(5):999-1050. PubMed ID: 12197546
    [No Abstract]   [Full Text] [Related]  

  • 2. Ugly wait at the counter. Insurer pushes to make allergy drugs nonprescription.
    Benko LB
    Mod Healthc; 2001 Aug; 31(32):22-3. PubMed ID: 11507861
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA approves OTC Claritin.
    FDA Consum; 2003; 37(1):3. PubMed ID: 12625285
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of the Rx-to-OTC switch of loratadine and changes in prescription drug benefits on utilization and cost of therapy.
    Sullivan PW; Nair KV; Patel BV
    Am J Manag Care; 2005 Jun; 11(6):374-82. PubMed ID: 15974556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managed care implications of the approval of generic or over-the-counter nonsedating antihistamines.
    Giaquinta D
    Manag Care Interface; 2002 Jun; 15(6):31-4. PubMed ID: 12087604
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessing patient satisfaction with desloratadine after conversion from loratadine, fexofenadine, or cetirizine.
    Glass D; Harper A
    Manag Care Interface; 2004 Feb; 17(2):29-34. PubMed ID: 15038691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over-the-counter drug products containing colloidal silver ingredients or silver salts. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Final rule.
    Fed Regist; 1999 Aug; 64(158):44653-8. PubMed ID: 10558603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The debate continues on OTC switches.
    Giaquinta D
    Manag Care Interface; 2003 Jun; 16(6):49-50. PubMed ID: 12841076
    [No Abstract]   [Full Text] [Related]  

  • 9. Laxative drug products for over-the-counter human use. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 Jan; 64(19):4535-40. PubMed ID: 10557608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiperspirant drug products for over-the-counter human use; final monograph. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Jun; 68(110):34273-93. PubMed ID: 12795305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rx: Canadian drugs.
    Zuger A
    N Engl J Med; 2003 Dec; 349(23):2188-90. PubMed ID: 14657425
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmaceutical provisions of the FDA Modernization Act of 1997: one year and counting.
    Binder GM
    Curr Opin Biotechnol; 1999 Jun; 10(3):303-6. PubMed ID: 10361077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Over-the-counter human drugs; labeling requirements; final rule; technical amendment. Food and Drug Administration, HHS. Final rule; technical amendment.
    Fed Regist; 2000 Jan; 65(1):7-9. PubMed ID: 11010625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergy warning.
    Underwood A
    Newsweek; 2002 Dec; 140(24):88. PubMed ID: 12500716
    [No Abstract]   [Full Text] [Related]  

  • 15. Importing prescription drugs: risky business.
    Hassel L; Arzuaga P
    Empl Benefits J; 2003 Dec; 28(4):83-6. PubMed ID: 14712740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coupon programs curb antihistamine utilization.
    Berberabe T
    Manag Care; 2003 Aug; 12(8):28-9. PubMed ID: 12966848
    [No Abstract]   [Full Text] [Related]  

  • 17. Making the most of the Rx-OTC switch. An interview with Charles A. Pergola [by John Covert].
    Pergola CA
    Am Pharm; 1984 Feb; NS24(2):34-8. PubMed ID: 6702589
    [No Abstract]   [Full Text] [Related]  

  • 18. Pediculicide drug products for over-the-counter human use; amendment of final monograph. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Dec; 68(250):75414-8. PubMed ID: 14986677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switching omeprazole in Sweden and the United States.
    Cohen J
    Am J Ther; 2003; 10(5):370-6. PubMed ID: 12975722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The FDA takes action against unapproved drugs.
    Meadows M
    FDA Consum; 2007; 41(1):34-5. PubMed ID: 17342837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.